Diaceutics PLC (DXRX) — Financial Flexibility Index
Diaceutics PLC (DXRX) has a Financial Flexibility Index of 0.07x as of December 2025. Free cash flow of GBX712.00K (operating CF GBX696.00K minus capex GBX16.00K) represents 0% of total liabilities (GBX9.53 Million). Check total reinvestment intensity of Diaceutics PLC to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Diaceutics PLC Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Diaceutics PLC across 10 annual periods. For the full cash flow conversion analysis, see Diaceutics PLC (DXRX) cash conversion ratio.
Annual Financial Flexibility Index for Diaceutics PLC (2016–2025)
Year-by-year free cash flow to debt coverage for Diaceutics PLC. Explore DXRX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.16x | GBX1.57 Million | GBX1.50 Million | GBX9.53 Million | ▼ -72.7% |
| 2024 | 0.60x | GBX5.28 Million | GBX651.00K | GBX8.76 Million | ▼ -45.7% |
| 2023 | 1.11x | GBX6.17 Million | GBX1.31 Million | GBX5.56 Million | ▼ -36.1% |
| 2022 | 1.74x | GBX9.97 Million | GBX5.10 Million | GBX5.74 Million | ▲ +22.7% |
| 2021 | 1.41x | GBX6.17 Million | GBX570.00K | GBX4.36 Million | ▼ -29.1% |
| 2020 | 2.00x | GBX6.55 Million | GBX253.00K | GBX3.28 Million | ▲ +94.3% |
| 2019 | 1.03x | GBX2.30 Million | GBX-627.05K | GBX2.24 Million | ▲ +3364.8% |
| 2018 | 0.03x | GBX153.59K | GBX-954.04K | GBX5.18 Million | ▼ -94.1% |
| 2017 | 0.50x | GBX1.82 Million | GBX1.53 Million | GBX3.61 Million | ▲ +73.7% |
| 2016 | 0.29x | GBX703.05K | GBX674.01K | GBX2.43 Million | — |